Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Danisco Finland Oy
Original Assignee
Pfizer Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US06/201,745external-prioritypatent/US4411925A/en
Priority claimed from DK321981Aexternal-prioritypatent/DK154652C/da
Application filed by Pfizer IncfiledCriticalPfizer Inc
Priority to CA000440870ApriorityCriticalpatent/CA1173450A/fr
Application grantedgrantedCritical
Publication of CA1173450ApublicationCriticalpatent/CA1173450A/fr
Process for refining a raw condensation product from aminoalkylalkanol amines and fatty acids, and as soon as required for the subsequent recovery of amphotensides with higher stability
Способ получени 3,6-ди-0-метил- @ -глюкозы и 1,2-0-алкилен-4-0-(пер-0-гексопиранозил)-3,6-ди-0-метил- @ - @ -глюкопираноза в качестве промежуточного продукта дл синтеза 3,6-ди-0-метил- @ -глюкозы